#5972

Mentioned in 5 episodes

Malignant

How Bad Policy and Bad Evidence Harm People with Cancer

Book • 2020

Vinayak K. Prasad, MD, MPH

In 'Malignant', Dr. Vinayak K. Prasad critiques the current state of oncology, highlighting issues such as lax regulatory standards, financial conflicts of interest, and the overemphasis on surrogate endpoints in clinical trials.

He argues for reforms to ensure that cancer drugs provide meaningful benefits at lower costs.

The book offers insights into how cancer trials are conducted and how drugs are approved, proposing solutions to improve cancer medicine.

Mentioned by

Mentioned in 5 episodes

Mentioned by

Bari Weiss

as the author of the book, highlighting his expertise in the field.

Will Ozempic Solve Obesity in America? A Debate

Mentioned by

Bob Kaplan

as a book he is currently reading, focusing on public health policy and cancer.

#103 - Looking back on the first 99 episodes: Strong Convictions, Loosely Held

Mentioned by

Vinay Prasad

as the book that discusses the state of cancer research and pharmaceuticals.

Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty

Mentioned by

Russ Roberts

in the introduction, referencing Dr.

Vinay Prasad

's previous appearance on the show.

Vinay Prasad on the Pandemic

Mentioned by

Peter Attia

as

Vinay Prasad

's book published this year, focusing on oncology.

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

Mentioned by

Russ Roberts

as the subject of the EconTalk episode and author of the book.

Vinay Prasad on Cancer Drugs, Medical Ethics, and Malignant

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

App store banner

Play store banner